About Surge Pharmaceuticals
Surge Pharmaceuticals is a Healthcare company based in Vadodara (India) founded in 2007. It manufactures and supplies affordable quality medicines worldwide through efficient facilities. It operates on a B2B and D2C model. The company has 18 employees. Its Indian entity Surge Pharmaceuticals Private Limited reported revenue of ₹25.94 Cr. Surge Pharmaceuticals offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Manufacturing, Drug Production and Distribution. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Surge Pharmaceuticals produces affordable and quality medicines, focusing on tablets and capsules at their Jejuri, Maharashtra, India facility. They offer contract manufacturing services with WHO-GMP and EU-GMP approvals, supported by a skilled technical team. The company delivers therapeutics for various diseases, emphasizing customer satisfaction and ethical standards, while serving global markets regardless of barriers.
- Headquarters Vadodara, India
- Employees 18
- SectorsHealthcare
- Email••••••••
- Website surgepharma.com
- Social LinkedIn Facebook Instagram
- Legal Name Surge Pharmaceuticals Private Limited
- Date of Incorporation 11 Sep, 2007
- Jurisdiction Vadodara, Gujarat, India
- Annual Revenue₹25.94 Cr
FY 2024 · 0% YoY
- Net Profit₹6.9 Lakh
FY 2024 · 0% margin
- EBITDA₹1.51 Cr
FY 2024 · 6% margin
- Employee Count18
Associated legal entities of Surge Pharmaceuticals
Surge Pharmaceuticals operates through Surge Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Surge Pharmaceuticals Private Limited CIN U24239GJ2007PTC051709 | Active | 11 Sep 2007 | Vadodara, Gujarat | ₹25.9 Cr | 18 | 2 | View details |
Products & Services of Surge Pharmaceuticals
Surge Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Manufactured tablets for treating various diseases affordably.
Manufactured capsules for therapeutic applications worldwide.
Board of directors of Surge Pharmaceuticals Private Limited (Surge Pharmaceuticals)
Surge Pharmaceuticals Private Limited is the primary company behind Surge Pharmaceuticals. The board of Surge Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Satyendra Kumar, appointed in 2007. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Satyendra Kumar DIN 01738299 | Director | 11 Sep 2007 | 19 yrs 1 mo | Surge Pharmaceuticals Private Limited |
| Bibhuti Kumar Verma DIN 01738363 | Director | 11 Sep 2007 | 19 yrs 1 mo | Surge Pharmaceuticals Private Limited |
Financials of Surge Pharmaceuticals
Figures of Surge Pharmaceuticals Private Limited, the primary company behind Surge Pharmaceuticals, for FY 2024. Revenue was ₹25.94 Cr (0% year on year). Net profit was ₹6.9 Lakh (0% margin). EBITDA was ₹1.51 Cr (6% margin). Revenue has grown at a compounded annual rate of +11% over three years and +14% over five years.
- ₹25.94 CrRevenue · FY 2024 · 0% YoY
- ₹6.9 LakhNet profit · 0% margin
- ₹1.51 CrEBITDA · 6% margin
- ₹65 LakhPaid-up capital
- 18Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Surge Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Surge Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Surge Pharmaceuticals
Surge Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Surge Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Surge Pharmaceuticals
Surge Pharmaceuticals was founded in 2007.
Surge Pharmaceuticals is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Surge Pharmaceuticals has 18 employees.
The primary company behind Surge Pharmaceuticals, Surge Pharmaceuticals Private Limited, reported revenue of ₹25.94 Cr for FY 2024, down 0% year on year.
Surge Pharmaceuticals produces affordable and quality medicines, focusing on tablets and capsules at their Jejuri, Maharashtra, India facility. They offer contract manufacturing services with WHO-GMP and EU-GMP approvals, supported by a skilled technical team. The company delivers therapeutics for various diseases, emphasizing customer satisfaction and ethical standards, while serving global markets regardless of barriers.
Surge Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Surge Pharmaceuticals offers Tablets and Capsules.
Surge Pharmaceuticals operates through Surge Pharmaceuticals Private Limited.
The legal entities of Surge Pharmaceuticals currently have 2 directors, including Satyendra Kumar, Bibhuti Kumar Verma.